http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-329861-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2005-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c02db35430c2be4e50eee8f97bc66a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e05242e843ddbbaa8eb86b74f0c8c2a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5093ccb0feba5847945e64dc749931e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c79ee99565f9ce4e0f3c7c073f9c14
publicationDate 2011-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-329861-B1
titleOfInvention New Process for the Synthesis of 1,3,4,5-Tetrahydro-2H-3-Benzazepin-2-One Compounds, and Use in the Synthesis of Ivabradine and Addition Salts thereof with a Pharmaceutically Acceptable Acid
abstract A process for the synthesis of compounds of formula (I) (I) wherein R 1 and R 2, which may be the same or different, each represent a linear or branched (C 1 -C 8) alkoxy group or together with the carbon atom bearing them, a 1,3-dioxane, 1,3-dioxolane or 1,3-dioxane ring. Use in the synthesis of ivabradine, addition salts thereof with a pharmaceutically acceptable acid and hydrates thereof.
priorityDate 2004-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID204232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415875325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 35.